Rapid Micro Biosystems, Inc.
RPID- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001380106
No open-market purchases or sales by Rapid Micro Biosystems, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Rapid Micro Biosystems, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 59 | 2 | 52 | −5 |
| Shares | 26.6M | 18.4K | 26.1M | −521.4K (−2.0%) |
| Value | $181.0M | $125.0K | $112.2M | −$68.6M (−38.0%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Rapid Micro Biosystems, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Industry Ventures, L.L.C. | 287,502 | $1.24M | 1.31% |
| Arena Investors LP | 235,000 | $1.01M | 0.47% |
| Oasis Management Co Ltd. | 187,617 | $807.0K | 0.15% |
| Millennium Management LLC | 109,128 | $469.0K | 0.00% |
| Hamilton Lane Advisors LLC | 97,916 | $421.0K | 0.16% |
| Susquehanna International Group, LLP | 91,760 | $395.0K | 0.00% |
| Ergoteles LLC | 70,400 | $303.0K | 0.01% |
| Gsa Capital Partners LLP | 29,835 | $128.0K | 0.02% |
| Citadel Advisors LLC | 29,713 | $128.0K | 0.00% |
| Bridgeway Capital Management, LLC | 28,500 | $123.0K | 0.00% |
| Boothbay Fund Management, LLC | 18,744 | $81.0K | 0.00% |
| Qube Research & Technologies Ltd | 13,099 | $56.0K | 0.00% |
| Schonfeld Strategic Advisors LLC | 10,000 | $43.0K | 0.00% |
| Sterling Investment Advisors, Ltd. | 654 | $3.00K | 0.00% |
| Credit Suisse AG | 8 | $0 | 0.00% |
| Ellevest, Inc. | 10 | $0 | 0.00% |
Sold out (21)
Institutions that held Rapid Micro Biosystems, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| D1 Capital Partners L.P.SuperinvestorD1 Capital Partners | 2,644,444 | $18.0M |
| Perceptive Advisors LLC | 190,745 | $1.29M |
| Woodline Partners LP | 130,600 | $887.0K |
| Jacobs Levy Equity Management, Inc | 94,173 | $639.0K |
| Charles Schwab Investment Management Inc | 35,478 | $241.0K |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd. | 34,583 | $235.0K |
| Nuveen Asset Management, LLC | 22,324 | $171.0K |
| Cinctive Capital Management LP | 25,178 | $171.0K |
| D. E. Shaw & Co., Inc. | 17,794 | $121.0K |
| Rhumbline Advisers | 10,611 | $72.0K |
| Deutsche Bank AG | 9,356 | $64.0K |
| American International Group, Inc. | 7,880 | $54.0K |
| California State Teachers Retirement System | 6,803 | $46.0K |
| Allspring Global Investments Holdings, LLC | 2,724 | $18.0K |
| STRS Ohio | 1,800 | $12.0K |
| Legal & General Group Plc | 1,542 | $10.0K |
| Amalgamated Bank | 1,241 | $8.00K |
| Royal Bank of Canada | 976 | $7.00K |
| Ameritas Investment Partners, Inc. | 613 | $4.00K |
| Sargent Bickham Lagudis LLC | 223 | $2.00K |
| TCWP LLC | 21 | $0 |
Not filed for Q2 2022 yet (2)
Institutions that held Rapid Micro Biosystems, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 17,158 | $117.0K |
| Amalgamated Financial Corp. | 1,241 | $8.00K |